Clinical trials are the backbone of medical innovation, yet many people are unsure about what participation entails. For the millions living with inflammatory bowel disease (IBD), a group of conditions including Crohn’s disease and ulcerative colitis, clinical trials offer hope for new therapies. According to a study by the Crohn’s & Colitis Foundation, nearly 1 in 100 Americans has IBD. These disorders cause inflammation of the intestines and can lead to debilitating symptoms. Research into IBD has the potential to change lives, but many trials face delays due to lack of enrollment. “We need more people to get involved in clinical trials, especially those from underrepresented communities, including people of color and older adults, who have some of the highest rates of chronic disease,” said Dr. Ruby Greywoode, a gastroenterologist at Montefiore Medical Center.
Clinical trials can take many forms, from medication studies to investigations of diet or emotional impact. Each trial is typically divided into four phases, which build on each other but are conducted separately. Phase 1 trials are the smallest and often involve healthy volunteers to determine safety, safe dosage ranges, and potential side effects. Phase 2 trials test the treatment in a slightly larger group of people who have the condition, to see if it works and to identify short-term side effects. Participants are randomly assigned to different treatment groups, which may include placebos. Phase 3 trials expand further, comparing the new drug against current treatments in a larger, more diverse group over a longer period. If results are strong, the company may submit an application to the FDA for approval. Phase 4 trials monitor the drug’s real-world use and effects after approval, often following thousands of patients for several years.
Understanding these phases can help patients make informed decisions about participation. For those with IBD, clinical trials offer a way to access new treatments and contribute to research that may help others. The Crohn’s & Colitis Foundation aims to make trials less mysterious and more accessible. As Dr. Greywoode noted, “Clinical trials give patients a real way to shape the future of treatment. It’s not just about their own care; it can help others, too.” Patients interested in learning more can explore resources at CrohnsColitisFoundation.org and search for IBD clinical trials at crohnscolitisfoundation.org/clinical-trials-community.


